Aventura Private Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119K Buy
945
+320
+51% +$42.2K 0.04% 227
2026
Q1
$87.1K Buy
625
+100
+19% +$14K 0.03% 245
2025
Q4
$64.4K Sell
525
-49
-9% -$5.96K 0.02% 264
2025
Q3
$63.8K Sell
574
-621
-52% -$70.6K 0.02% 268
2025
Q2
$133K Buy
1,195
+51
+4% +$5.43K 0.06% 175
2025
Q1
$128K Buy
1,144
+18
+2% +$1.86K 0.07% 172
2024
Q4
$104K Buy
+1,126
New +$101K 0.06% 183

Other funds holding GILD

Aventura Private Wealth's GILD Position: Q2 2026 in Review

Aventura Private Wealth increased its Gilead Sciences (GILD) stake by 51% in Q2 2026, buying an estimated $42.2K and bringing the position to 945 shares worth $119K. The position accounts for 0.04% of the portfolio, ranked #227.

Aventura Private Wealth first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $133K in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Aventura Private Wealth held 945 shares of Gilead Sciences worth $119K as of Q2 2026.
  • Aventura Private Wealth bought 320 Gilead Sciences shares in Q2 2026, an estimated $42.2K.
  • Gilead Sciences made up 0.04% of Aventura Private Wealth's portfolio in Q2 2026, its #227 holding.
  • Aventura Private Wealth first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Aventura Private Wealth's Gilead Sciences position peaked at $133K in Q2 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.